Cargando…

Interferon Regulatory Factor 9 Promotes Lung Cancer Progression via Regulation of Versican

SIMPLE SUMMARY: Lung cancer is the leading cause of cancer-related deaths worldwide, accounting for more than 1.6 million deaths per year. The tumor microenvironment (TME) has been shown to play a crucial role in tumor progression and metastasis, and transcription factors link TME signaling to oncog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brunn, David, Turkowski, Kati, Günther, Stefan, Weigert, Andreas, Muley, Thomas, Kriegsmann, Mark, Winter, Hauke, Dammann, Reinhard H., Stathopoulos, Georgios T., Thomas, Michael, Guenther, Andreas, Grimminger, Friedrich, Pullamsetti, Soni S., Seeger, Werner, Savai, Rajkumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827113/ https://www.ncbi.nlm.nih.gov/pubmed/33430083 http://dx.doi.org/10.3390/cancers13020208

Ejemplares similares

Fibroblast Growth Factor—14 Acts as Tumor Suppressor in Lung Adenocarcinomas
por: Turkowski, Kati, et al.
Publicado: (2020)

Picturing of the Lung Tumor Cellular Composition by Multispectral Flow Cytometry
por: Olesch, Catherine, et al.
Publicado: (2022)

Fibrocytes boost tumor-supportive phenotypic switches in the lung cancer niche via the endothelin system
por: Weigert, Andreas, et al.
Publicado: (2022)

Epigenetic Inactivation of the Tumor Suppressor IRX1 Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated with Impaired Prognosis
por: Küster, Miriam M., et al.
Publicado: (2020)

Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy
por: Zheng, Xiang, et al.
Publicado: (2017)

Reprogramming of tumor-associated macrophages by targeting β-catenin/FOSL2/ARID5A signaling: A potential treatment of lung cancer
por: Sarode, Poonam, et al.
Publicado: (2020)

Hidden Treasures: Macrophage Long Non-Coding RNAs in Lung Cancer Progression
por: Karger, Annika, et al.
Publicado: (2021)

Immune and Inflammatory Cell Composition of Human Lung Cancer Stroma
por: Banat, G-Andre, et al.
Publicado: (2015)

Epigenetic silencing of downstream genes mediated by tandem orientation in lung cancer
por: Kiehl, Steffen, et al.
Publicado: (2017)

Exposomes to Exosomes: Exosomes as Tools to Study Epigenetic Adaptive Mechanisms in High-Altitude Humans
por: Padmasekar, Manju, et al.
Publicado: (2021)

A FOX-like Mechanism Regulating Lung Fibroblasts: Are We Getting There?
por: Pullamsetti, Soni Savai, et al.
Publicado: (2020)

Metabolism in tumour-associated macrophages: a quid pro quo with the tumour microenvironment
por: Zheng, Xiang, et al.
Publicado: (2020)

Reply to Zheng et al.
por: Eul, Bastian, et al.
Publicado: (2021)

ADPGK‐AS1 long noncoding RNA switches macrophage metabolic and phenotypic state to promote lung cancer growth
por: Karger, Annika, et al.
Publicado: (2023)

Phosphodiesterase 6 subunits are expressed and altered in idiopathic pulmonary fibrosis
por: Nikolova, Sevdalina, et al.
Publicado: (2010)

Correction to: Phosphodiesterase 6 subunits are expressed and altered in idiopathic pulmonary fibrosis
por: Nikolova, Sevdalina, et al.
Publicado: (2022)

A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
por: Dabral, Swati, et al.
Publicado: (2019)

Epigenetic Mechanisms in Parenchymal Lung Diseases: Bystanders or Therapeutic Targets?
por: Avci, Edibe, et al.
Publicado: (2022)

The Multi-Modal Effect of the Anti-fibrotic Drug Pirfenidone on NSCLC
por: Marwitz, Sebastian, et al.
Publicado: (2020)

Zooming into Cellular and Molecular Heterogeneity of Pulmonary Hypertension. What More Single-Cell Omics Can Offer
por: Chelladurai, Prakash, et al.
Publicado: (2021)

New Insights into the Epigenomic Landscape of Small-Cell Lung Cancer: A Game Changer?
por: Sarode, Poonam, et al.
Publicado: (2022)

Cancer and pulmonary hypertension: Learning lessons and real-life interplay
por: Pullamsetti, Soni Savai, et al.
Publicado: (2020)

FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis
por: Al‐Tamari, Hamza M, et al.
Publicado: (2017)

Epigenetic mechanisms in pulmonary arterial hypertension: the need for global perspectives
por: Chelladurai, Prakash, et al.
Publicado: (2016)

Correction to: Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice
por: Udalov, Sergey, et al.
Publicado: (2022)

Long Noncoding RNAs: Emerging Regulators of Platelet-derived Growth Factor Signaling
por: Valasarajan, Chanil, et al.
Publicado: (2022)

Characterization of a murine model of monocrotaline pyrrole-induced acute lung injury
por: Dumitrascu, Rio, et al.
Publicado: (2008)

Hypoxic pulmonary hypertension in mice with constitutively active platelet-derived growth factor receptor-β
por: Dahal, Bhola K., et al.
Publicado: (2011)

Phosphodiesterase 10A Upregulation Contributes to Pulmonary Vascular Remodeling
por: Tian, Xia, et al.
Publicado: (2011)

Macrophage and Tumor Cell Cross-Talk Is Fundamental for Lung Tumor Progression: We Need to Talk
por: Sarode, Poonam, et al.
Publicado: (2020)

Non-Oncogene Addiction of KRAS-Mutant Cancers to IL-1β via Versican and Mononuclear IKKβ
por: Spella, Magda, et al.
Publicado: (2023)

Glycogen Synthase Kinase 3beta Contributes to Proliferation of Arterial Smooth Muscle Cells in Pulmonary Hypertension
por: Sklepkiewicz, Piotr, et al.
Publicado: (2011)

Myeloid-cell-specific deletion of inducible nitric oxide synthase protects against smoke-induced pulmonary hypertension in mice
por: Gredic, Marija, et al.
Publicado: (2022)

Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice
por: Udalov, Sergey, et al.
Publicado: (2010)

EpiHope for the Treatment of Pulmonary Arterial Hypertension: Selective versus Nonselective BET Inhibition
por: Pullamsetti, Soni Savai, et al.
Publicado: (2019)

Mechanics and mechanisms of pulmonary hypertension—Conference summary and translational perspectives
por: Seeger, Werner, et al.
Publicado: (2013)

Prognostic Impact of PD-L1 Expression in pN1 NSCLC: A Retrospective Single-Center Analysis
por: Eichhorn, Florian, et al.
Publicado: (2021)

Utility and Drawbacks of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Lung Cancer
por: Kandra, Prameela, et al.
Publicado: (2022)

Inactivation of nuclear histone deacetylases by EP300 disrupts the MiCEE complex in idiopathic pulmonary fibrosis
por: Rubio, Karla, et al.
Publicado: (2019)

In-Silico Design of a Novel Tridecapeptide Targeting Spike Protein of SARS-CoV-2 Variants of Concern
por: Rajpoot, Sajjan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_csa1vujlg4oecj22bk8fut5hgm